This study explored how a sample of Australian pharmacists would convey information about the side effects of a medicine, if they were to counsel a patient. A qualitative method was selected and written responses to a case-based scenario were analysed using inductive thematic analysis. The grounded theory approach elicited a fluid and dynamic model for side effect counselling. The study identified strategies for counselling, such as encouraging adherence through emphasising the benefits of the medication, referral to the prescriber, and providing empathy and reassurance to ease anxiety and address concerns. Pharmacists acknowledged the potential for risk, although only a minority used numerical descriptors. The final themes or outcomes were that pharmacists aim to allay fears, minimise harm and promote medication use when counselling about side effects. Professional empathy, the acknowledgment of patient concerns, and the importance of providing tailored information to promote medication adherence, emerged as features of the quality use of medicines. This study contributes to existing literature by identifying the role of allaying patients’ fears when conveying side effect information. It also describes a process to convey tailored information. Implications for practice include the importance of effective use of communication strategies to encourage adherence, as the appropriate use of medication can lead to positive health outcomes.
References
[1]
Ziegler, D.; Mosier, M.; Buenaver, M.; Okuyemi, L. How Much Information About Adverse Effects of Medication Do Patients Want From Physicians? Arch. Intern. Med. 2001, 161, 706–713, doi:10.1001/archinte.161.5.706.
[2]
Bowskill, R.; Clatworthy, J.; Parham, R.; Rank, T.; Horne, R. Patients’ perceptions of information received about medication prescribed for bipolar disorder: implications for informed choice. J. Affect. Disord. 2007, 100, 253–257, doi:10.1016/j.jad.2006.10.018.
[3]
Enlund, H.; Vainio, K.; Wallenius, S.; Poston, J.W. Adverse drug effects and the need for drug information. Med. Care 1991, 29, 558–564, doi:10.1097/00005650-199106000-00014.
[4]
Nair, K.; Dolovich, L.; Cassels, A.; McCormack, J.; Levine, M.; Gray, J.; Mann, K.; Burns, S. What patients want to know about their medications. Focus group study of patient and clinician perspectives. Can. Fam. Physician. 2002, 48, 104–110.
[5]
Tarn, D.M.; Paterniti, D.A.; Williams, B.R.; Cipri, C.S.; Wenger, N.S. Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives. J. Am. Geriatr. Soc. 2009, 57, 462–469, doi:10.1111/j.1532-5415.2008.02133.x.
[6]
Bajcar, J. Task analysis of patients' medication-taking practice and the role of making sense: A grounded theory study. Res. Soc. Admin. Pharm. 2006, 2, 59–82, doi:10.1016/j.sapharm.2005.12.005.
[7]
Horne, R.; Weinman, J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J. Psychosom. Res. 1999, 47, 555–567, doi:10.1016/S0022-3999(99)00057-4.
[8]
Okuyan, B.; Sancar, M.; Izzettin, F.V. Assessment of medication knowledge and adherence among patients under oral chronic medication treatment in community pharmacy settings. Pharmacoepidem. Dr. S. 2013, 22, 209–214, doi:10.1002/pds.3275.
[9]
McGrath, J.M. Physicians’ perspectives on communicating prescription drug information. Qual. Health Res. 1999, 9, 731–745, doi:10.1177/104973299129122243.
[10]
Schommer, J.; Wiederholt, J. Pharmacists’ views of patient counselling. Am. Pharm. 1994, NS34, 46–53.
[11]
Makoul, G.; Arntson, P.; Schofield, T. Health promotion in primary care: physician-patient communication and decision making about precription medications. Soc. Sci. Med. 1995, 41, 1241–1254, doi:10.1016/0277-9536(95)00061-B.
[12]
Berry, D.; Michas, I.; Gillie, T.; Forster, M. What do patients want to know about their medicines, and what do doctors want to tell them?: A comparative study. Psych. Health. 1997, 12, 467–480, doi:10.1080/08870449708406723.
[13]
Mottram, D.R.; Reed, C. Comparative evaluation of patient information leaflets by pharmacists, doctors and the general public. J. Clin. Pharm. Ther. 1997, 22, 127–134, doi:10.1111/j.1365-2710.1997.tb00006.x.
[14]
Sleath, B.; Wurst, K. Patient receipt of, and preferences for receiving, antidepressant information. Int. J. Pharm. Pract. 2002, 10, 235–241, doi:10.1211/096176702776868442.
[15]
McAuley, J.W.; Miller, M.A.; Klatte, E.; Shneker, B.F. Patients with epilepsy’s perception on community pharmacist’s current and potential role in their care. Epilepsy Behav. 2009, 14, 141–145, doi:10.1016/j.yebeh.2008.10.014.
[16]
Wiedenmayer, K.; Summers, R.; Mackie, C.; Gous, A.; Everard, M. Developing pharmacy practice: A focus on patient care. Available online: http://www.fip.org/files/fip/publications/DevelopingPharmacyPractice/DevelopingPharmacyPracticeEN.pdf. (accessed on 10 September 2013).
[17]
Professional Practice Standards version 4: Standard 3: Counselling. Available online: http://www.psa.org.au/supporting-practice/professional-practice-standards/version-4 (accessed on 10 September 2013).
[18]
Barnett, N. Developing your consultation skills to support medicines adherence. Clin. Pharm. 2012, 4, 266–268.
[19]
Pilnick, A. “Patient counseling” by pharmacists: Four approaches to the delivery of counselling sequences and their interactional reception. Soc. Sci. Med. 2003, 56, 835–849, doi:10.1016/S0277-9536(02)00082-5.
[20]
Dyck, A.; Deschamps, M.; Taylor, J. Pharmacists’ discussions of medication side effects: A descriptive study. Patient Educ. Couns. 2005, 56, 21–27, doi:10.1016/j.pec.2003.10.006.
[21]
Shah, B.; Chewning, B. Conceptualising and measuring pharmacist-patient communications: A review of published studies. Res. Soc. Admin. Pharm. 2006, 2, 153–185, doi:10.1016/j.sapharm.2006.05.001.
[22]
Charmaz, K. Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis; Thousand Oaks: California, CA, USA, 2006.
[23]
Australian Government Department of Health. PBS Expenditure and Prescriptions: Expenditure and Prescriptions twelve months to 30 June 2012. Available online: http://www.pbs.gov.au/info/statistics/expenditure-and-prescriptions-30-06-2012 (accessed on 21 November 2013).
[24]
Ferrari, A. Headache: One of the most common and troublesome adverse reactions to drugs. Curr. Drug. Saf. 2006, 1, 43–58, doi:10.2174/157488606775252610.
[25]
Triantafyllou, K.; Vlachogiannakos, J.; Ladas, S.D. Gastrointestinal and liver side effects of drugs in elderly patients. Best. Pract. Res. Cl. Ga. 2010, 24, 203–215, doi:10.1016/j.bpg.2010.02.004.
[26]
Pharmacy Board of Australia. Available online: http://www.pharmacyboard.gov.au/Codes-Guidelines.aspx (accessed on 30 October 2013).
[27]
The Society of Hospital Pharmacists of Australia. Available online: http://www.shpa.org.au/About (accessed on 30 October 2013).
[28]
Australian Association of Consultant Pharmacy. Available online: http://www.aacp.com.au/ (accessed on 30 October 2013).
[29]
Corbin, J. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory; Thousand Oaks: California, CA, USA, 2008.
[30]
Glaser, B.G.; Strauss, A.L. The Discovery of Grounded Theory; Aldine Publishing Company: Chicago, IL, USA, 1967.
[31]
Australian Health Practitioner Registration Authority. Pharmacy Board of Australia: Data tables. June 2012. Available online: http://www.ahpra.gov.au (accessed on 10 September 2013).
[32]
Australian Government Deaprtment of Health. Quality Use of Medicines (QUM). Available online: http://www.health.gov.au/internet/main/publishing.nsf/Content/nmp-quality.htm (accessed on 30 October 2013).
[33]
Hargie, O.; Morrow, N.; Woodman, C. Pharmacists’ evaluation of key communication skills in practice. Patient Educ. Couns. 2000, 39, 61–70, doi:10.1016/S0738-3991(99)00091-9.
[34]
Kimberlin, C.L. Communicating with patients: Skills assessment in US colleges of pharmacy. Am. J. Pharm. Educ. 2006, 70, 67, doi:10.5688/aj700367.
[35]
Blom, L.; Wolters, M.; Hoor-Suykerbuyk, M.T.; van Paassen, J.; van Oyen, A. Pharmaceutical education in patient counselling: 20 h spread over 6 years? Patient Educ. Couns. 2011, 83, 465–471, doi:10.1016/j.pec.2011.05.018.
[36]
Kokkinn, B.; Stupans, I. Improving pharmacy counseling skills: an interdisciplinary model of support for students with English as an additional language. Int. J. Pharm. Pract. 2011, 19, 435–437, doi:10.1111/j.2042-7174.2011.00149.x.
[37]
Krueger, K.P.; Berger, B.A.; Felkey, B. Medication adherence and persistence: A comprehensive review. Adv. Ther. 2005, 22, 313–356, doi:10.1007/BF02850081.
[38]
Berry, D.C.; Raynor, D.K.; Knapp, P.; Bersellini, E. Patients’ understanding of risk associated with medication use: Impact of European Commission Guidelines and other risk scales. Drug Safety 2003, 26, 1–11, doi:10.2165/00002018-200326010-00001.
[39]
Knapp, P.; Raynor, D.K.; Berry, D.C. Comparison of two methods of presenting risk information to patients about the side effects of medicines. Qual. Saf. Health Care 2004, 13, 176–180, doi:10.1136/qshc.2003.009076.
[40]
Berkman, N.D.; Sheridan, S.L.; Donahue, K.E.; Halpern, D.J.; Crotty, K. Low health literacy and health outcomes: An updated systematic review. Ann. Intern. Med. 2011, 155, 97–107, doi:10.7326/0003-4819-155-2-201107190-00005.
[41]
Lipkus, I.M. Numeric, verbal, and visual formats of conveying health risks: Suggested best practices and future recommendations. Med. Decis. Making. 2007, 27, 696–713, doi:10.1177/0272989X07307271.
[42]
Frankel, R.M.; Stein, T. Getting the most out of the clinic encounter: The Four Habits Model. Perm. J. 1999, 3, 79–88.
[43]
McHorney, C.A. The Adherence Estimator: A brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr. Med. Res. Opin. 2009, 25, 215–238, doi:10.1185/03007990802619425.
[44]
ABC News. Brisbane floods: before and after. Available online: http://www.abc.net.au/news/specials/qld-floods/ (accessed on 30 October 2013).
